Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
1.
Front Immunol ; 15: 1339660, 2024.
Article in English | MEDLINE | ID: mdl-38464527

ABSTRACT

Coronavirus disease 2019 (COVID-19), which is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a global pandemic. The Omicron variant (B.1.1.529) was first discovered in November 2021 in specimens collected from Botswana, South Africa. Omicron has become the dominant variant worldwide, and several sublineages or subvariants have been identified recently. Compared to those of other mutants, the Omicron variant has the most highly expressed amino acid mutations, with almost 60 mutations throughout the genome, most of which are in the spike (S) protein, especially in the receptor-binding domain (RBD). These mutations increase the binding affinity of Omicron variants for the ACE2 receptor, and Omicron variants may also lead to immune escape. Despite causing milder symptoms, epidemiological evidence suggests that Omicron variants have exceptionally higher transmissibility, higher rates of reinfection and greater spread than the prototype strain as well as other preceding variants. Additionally, overwhelming amounts of data suggest that the levels of specific neutralization antibodies against Omicron variants decrease in most vaccinated populations, although CD4+ and CD8+ T-cell responses are maintained. Therefore, the mechanisms underlying Omicron variant evasion are still unclear. In this review, we surveyed the current epidemic status and potential immune escape mechanisms of Omicron variants. Especially, we focused on the potential roles of viral epitope mutations, antigenic drift, hybrid immunity, and "original antigenic sin" in mediating immune evasion. These insights might supply more valuable concise information for us to understand the spreading of Omicron variants.


Subject(s)
COVID-19 , SARS-CoV-2 , Humans , SARS-CoV-2/genetics , Immune Evasion/genetics , Antibodies , Pandemics
2.
Mol Immunol ; 169: 28-36, 2024 May.
Article in English | MEDLINE | ID: mdl-38493579

ABSTRACT

Our previous work has demonstrated that the tetraspan MS4A6D interacts with MHC-II to be a complex that promotes macrophage activation (Mol Immunol. 2023; 160: 121-132), however, the exact role of MS4A6D in controlling macrophage-derived inflammation is still poorly understood. Here, we showed that Ms4a6d-deficient (Ms4a6d-/-) mice manifested a lower level of footpad swelling induced by subcutaneous injection of 100 µL of 1% Carrageenan (CGN, w/v) plus CaCl2 (50 mM), a phenomenon that is similar to Nlrp3-/-, Casp-1-/-, and Ilr1-/- mice. Mechanistically, F4/80+ macrophages infiltrated in the footpad tissues of the Ms4A6d-/- mice was significantly lower than that of the WT littermates, leading to dramatically lower levels of proIL-1ß in vivo. Moreover, macrophages from Ms4a6d-/- mice also showed a dramatical reduction of Il-1ß secretion following NLRP3 inflammsome activation in vitro. Interestingly, both Ms4a6dC237G mutant (Interruption of MS4A6D homodimerization) and Ms4a6dY241G mutant (deletion of heITAM motif) mice also significantly inhibited CGN-induced footpad swelling due to lower levels of Il-1ß secretion in vivo. Collectively, MS4A6D aggravates CGN-induced footpad swelling in mice by enhancing NLRP3 inflammasome in macrophages and inducing the release of IL-1ß, indicating that MS4A6D promotes the progression of acute inflammation.


Subject(s)
Macrophages , Animals , Mice , Carrageenan , Inflammasomes , Inflammation/chemically induced , Interleukin-1beta , Mice, Inbred C57BL , NLR Family, Pyrin Domain-Containing 3 Protein/genetics
3.
Front Surg ; 8: 663377, 2021.
Article in English | MEDLINE | ID: mdl-34150839

ABSTRACT

It is commonly observed that patients with bone fracture concomitant with traumatic brain injury (TBI) had significantly increased fracture healing, but the underlying mechanisms were not fully revealed. Long non-coding RNAs (lncRNAs) are known to play complicated roles in bone homeostasis, but their role in TBI accelerated fracture was rarely reported. The present study was designed to determine the role of lncRNAs in TBI accelerated fracture via transcriptome sequencing and further bioinformatics analyses. Blood samples from three fracture-only patients, three fracture concomitant with TBI patients, and three healthy controls were harvested and were subsequently subjected to transcriptome lncRNA sequencing. Differentially expressed genes were identified, and pathway enrichment was performed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. High-dimensional data visualization by self-organizing map (SOM) machine learning was applied to further interpret the data. An xCell method was then used to predict cellular behavior in all samples based on gene expression profiles, and an lncRNA-cell interaction network was generated. A total of 874 differentially expressed genes were identified, of which about 26% were lncRNAs. Those identified lncRNAs were mainly enriched on TBI-related and damage repair-related pathways. SOM analyses revealed that those differentially expressed lncRNAs could be divided into three major module implications and were mainly enriched on transcriptional regulation and immune-related signal pathways, which promote us to further explore cellular behaviors based on differentially expressed lncRNAs. We have predicted that basophils, CD8+ T effector memory cells, B cells, and naïve B cells were significantly downregulated, while microvascular endothelial cells were predicted to be significantly upregulated in the Fr/TBI group, was the lowest and highest, respectively. ENSG00000278905, ENSG00000240980, ENSG00000255670, and ENSG00000196634 were the most differentially expressed lncRNAs related to all changes of cellular behavior. The present study has revealed for the first time that several critical lncRNAs may participate in TBI accelerated fracture potentially via regulating cellular behaviors of basophils, cytotoxic T cells, B cells, and endothelial cells.

4.
J Chromatogr Sci ; 59(9): 806-812, 2021 Sep 29.
Article in English | MEDLINE | ID: mdl-33598689

ABSTRACT

In order to comprehensively reflect the cigarette quality, a method combining direct injection of diluted sample with high sensitive high-performance liquid chromatography (HPLC)- electrospray (ESI)- quadrupole (Q)- time of flight (TOF)- tandem mass spectrometry (MS/MS) was developed for the identification of major components of cigarette essences (jujube and mulberry extracts). Based on the observed relative molecular mass, MS/MS fragmentation behavior, MS/MS database and related literatures, the components of the jujube extract and mulberry extract were identified. The result shows that the composition of jujube extract and mulberry extract has some similarity. They all mainly contain amino acids, free amino compounds and Maillard reaction products, which are the main constituents of a cigarette essence.


Subject(s)
Drugs, Chinese Herbal , Morus , Ziziphus , Chromatography, High Pressure Liquid , Plant Extracts , Spectrometry, Mass, Electrospray Ionization , Tandem Mass Spectrometry
5.
J AOAC Int ; 104(3): 712-718, 2021 Jun 12.
Article in English | MEDLINE | ID: mdl-33252696

ABSTRACT

BACKGROUND: Some volatile compounds in mouthpiece cigarette adhesive emit irritating odors and affect the taste of smoking cigarettes. Therefore, it is necessary to monitor the volatile compounds in mouthpiece cigarette adhesive. OBJECTIVES: A rapid and simple analytical method of volatile compounds in mouthpiece cigarette adhesive was established. METHODS: In this study, headspace (HS) injection coupled with GC-MS was utilized for qualitative and quantitative analysis. Initially, the volatile compounds in mouthpiece cigarette adhesives were detected by HS-GC-MS, followed by spectrum library retrieval. The detected compounds with the similarity to a spectrum library of more than 85% were further identified by comparing the retention time and mass spectra of the detected volatile compounds and those of the corresponding standard samples. The quantitative analysis of nine identified volatile compounds was performed. RESULTS: Eleven volatile compounds in the mouthpiece cigarette adhesive were accurately identified. The quantitative analytical method of nine volatile compounds in mouthpiece cigarette adhesive was validated to have good linearities (R2 > 0.9932) within the range of 20-5000 ng/g. The detection limits of 9 compounds were within the range of 3.1-147.7 ng/g. The intra- and inter-day relative standard deviations were less than 19.8%. The recoveries of these 9 compounds spiked into mouthpiece cigarette adhesive were 68.1-108.3%. CONCLUSIONS: The proposed method is rapid, simple, and accurate for qualitative and quantitative analysis of volatile compounds in the mouthpiece cigarette adhesive. HIGHLIGHTS: The developed analytical method is expected to be used to monitor volatile compounds in various adhesives.


Subject(s)
Tobacco Products , Volatile Organic Compounds , Adhesives , Gas Chromatography-Mass Spectrometry , Solid Phase Microextraction , Volatile Organic Compounds/analysis
6.
J Chromatogr Sci ; 59(1): 23-29, 2021 Jan 01.
Article in English | MEDLINE | ID: mdl-33078189

ABSTRACT

In our present study, the standard chemicals of triacetin were purified by reverse-phase and normal-phase semi-preparative high-performance liquid chromatography (HPLC), and 1H NMR and 13C NMR were employed to determine the purity and structure of triacetin. Moreover, a simple and rapid HPLC-photodiode array (PDA) method was developed to determine the contents of triacetin in 30 batches from different suppliers. The chromatographic separation was performed on a Phenomenex Gemini-NX C18 column (250 × 4.6 mm, 5 µm) using a gradient elution system of water and acetonitrile (contained 0.1% of formic acid) solution with a flow rate of 1.0 mL/min at 30°C at 210 nm. Sample preparation method is rapid and energy efficient, and the obtained sample have a good purity. Validation shows good specificity, linearity (R2 = 0.9995), precision, stability, repeatability (% RSD < 2.80) and the average recovery (99.72%) of triacetin. The content of triacetin in most samples is concentrated in 94-97%. This developed approach is simple, rapid, accurate and can be used to quickly determine the purity and the content of triacetin in plasticizers and filter plugs.


Subject(s)
Chromatography, High Pressure Liquid/methods , Triacetin/analysis , Triacetin/chemistry , China , Chromatography, Reverse-Phase , Drug Contamination , Linear Models , Reproducibility of Results , Sensitivity and Specificity
7.
Sci Adv ; 5(1): eaau7426, 2019 01.
Article in English | MEDLINE | ID: mdl-30662948

ABSTRACT

Hyperactivation of the NLRP3 inflammasome contributes to the pathogenesis of multiple diseases, but the mechanisms underlying transcriptional regulation of Nlrp3 remain elusive. We demonstrate here that macrophages lacking V-set and immunoglobulin domain-containing 4 (Vsig4) exhibit significant increases in Nlrp3 and Il-1ß transcription, caspase-1 activation, pyroptosis, and interleukin-1ß (IL-1ß) secretion in response to NLRP3 inflammasome stimuli. VSIG4 interacts with MS4A6D in the formation of a surface signaling complex. VSIG4 occupancy triggers Ser232 and Ser235 phosphorylation in MS4A6D, leading to activation of JAK2-STAT3-A20 cascades that further results in nuclear factor κB suppression and Nlrp3 and Il-1ß repression. Exaggerated NLRP3 and IL-1ß expression in Vsig4-/- mice is accountable for deleterious disease severity in experimental autoimmune encephalomyelitis (EAE) and resistance to dextran sulfate sodium (DSS)-induced colitis. The agonistic VSIG4 antibodies (VG11), acting through NLRP3 and IL-1ß suppression, show significant therapeutic efficacy in mouse EAE. These findings highlight VSIG4 as a prospective target for treating NLRP3-associated inflammatory disorders.


Subject(s)
Interleukin-1beta/metabolism , Macrophages/metabolism , NLR Family, Pyrin Domain-Containing 3 Protein/metabolism , Receptors, Complement/metabolism , Transcription, Genetic , Animals , Antibodies, Monoclonal/therapeutic use , Colitis/chemically induced , Colitis/metabolism , Dextran Sulfate/pharmacology , Encephalomyelitis, Autoimmune, Experimental/chemically induced , Encephalomyelitis, Autoimmune, Experimental/drug therapy , Encephalomyelitis, Autoimmune, Experimental/metabolism , Female , HEK293 Cells , Humans , Inflammasomes/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Myelin-Oligodendrocyte Glycoprotein/pharmacology , Peptide Fragments/pharmacology , RAW 264.7 Cells , Receptors, Complement/genetics , Receptors, Complement/immunology , THP-1 Cells
8.
RSC Adv ; 9(58): 33848-33852, 2019 Oct 18.
Article in English | MEDLINE | ID: mdl-35528873

ABSTRACT

Tobacco stalk, a kind of agricultural residue, will cause environmental pollution because it contains some harmful substances such as nicotine. To realize the high-value utilization of this agricultural residue, we prepared porous carbon (TS-C) by high temperature carbonization using tobacco stalk as a precursor. It was found that TS-C displays a hierarchical pore structure and high Brunauer-Emmett-Teller (BET) surface area of 1416 m2 g-1. Moreover, TS-C has excellent performance in organic dye adsorption at room temperature, especially for Gentian violet (GV), with the maximum adsorption capacity of 926 mg g-1.

9.
J Cancer ; 8(5): 816-824, 2017.
Article in English | MEDLINE | ID: mdl-28382144

ABSTRACT

Bladder cancer is one of most common malignant cancer. Although previous studies have found abnormal expression of B7-H3 in human bladder cancer tissues, the exact role and molecular mechanism of B7-H3 in bladder cancer remain unknown. In this study, we first detected the expression of B7-H3 in human bladder cancer samples and cell lines, and analyzed its correlations with clinicopathological pathological parameters. Next, siRNAs or overexpression plasmids of B7-H3 were transfected into T24 or 5637 cells, and cell proliferation, apoptosis, migration and invasion were analyzed via CCK-8, colony formation, flow cytometry and transwell assays, protein expression levels were determined by western blotting. The results presented here showed B7-H3 was upregulated in bladder cancer samples compared with normal tissues, and the expression level was correlated with local invasion status. B7-H3 did not affect cell proliferation and apoptosis, but cell migration and invasion were changed through the regulation of matrix metalloproteinase (MMP) 2/9. Knockdown of B7-H3 resulted in decreased activity of the STAT3 and PI3K/Akt pathways, and the Akt served as an upstream regulator of the STAT3. Our results suggest that the overexpression of B7-H3 promotes the migration and invasion of human bladder cancer cells through the PI3K/Akt/STAT3 signaling pathway.

10.
Biotechnol Lett ; 38(11): 1867-1873, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27421965

ABSTRACT

OBJECTIVE: To design a specific polyclonal antibody against Deinagkistrodon acutus venom (DA-pAb) by immunizating New Zealand white rabbits. RESULTS: The IgG fraction was purified by affinity chromatography, and specific antibodies were purified by immunoaffinity chromatography. Polyclonal antibodies were subjected to ELISA and western blotting to evaluate their immune reactivity. We identified the mimotopes by screening a phage display 12-mer peptide library against D. acutus venom. After three rounds of biopanning with DA-pAb, 30 positive clones were identified. Eighteen phage clones were sequenced, and their corresponding amino acid sequences were deduced. Additional immunoassays with the peptides and DA-pAb identified five sequences as possible epitopes. Recombinant antigens synthesized with the five epitopes were used for the immunization of BALB/c mice. CONCLUSION: The antibodies induced by these peptides recognized the recombinant antigen and D. acutus venom and protected mice against the hemorrhagic effects of the venom.


Subject(s)
Crotalid Venoms/immunology , Epitopes/immunology , Immunoglobulin G/isolation & purification , Viperidae/metabolism , Amino Acid Sequence , Animals , Chromatography, Affinity , Crotalid Venoms/chemistry , Crotalid Venoms/genetics , Epitopes/genetics , Immunization , Immunoglobulin G/immunology , Immunoglobulin G/metabolism , Male , Mice , Peptide Library , Rabbits , Sequence Analysis, Protein , Viperidae/genetics , Viperidae/immunology
11.
Medicine (Baltimore) ; 94(45): e1988, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26559284

ABSTRACT

Although acute mountain sickness (AMS) has long been recognized, little is known about this condition to date. The current study was conducted to explore changes in the metabolomic profiles of AMS patients and to further assess the potential of using these changes for the diagnosis of AMS. Plasma samples from 12 patients with AMS and 12 individuals without AMS were collected and used for further bioinformatics analysis by gas chromatography-mass spectrometry (GC-MS). The following analytical methods were used: gas chromatography-mass spectrometry data preprocessing, principal components analysis, partial least squares-discriminant analysis, model validation, orthogonal partial least squares-discriminant analysis, and the screening and identification of differences in metabolites. The results revealed a significantly difference between the subjects with AMS and those in the control group. Compared with plasma from the controls, plasma from the AMS patients contained significantly increased hypoxanthine, cysteinylglycine, D-arabitol, L-allothreonine, 2-ketobutyric acid, and succinate semialdehyde. The identification of metabolomic changes may be useful for the diagnosis of AMS in the future and may lay the foundation for further study of AMS pathogenesis.


Subject(s)
Altitude Sickness/blood , Adult , Gas Chromatography-Mass Spectrometry , Healthy Volunteers , Humans , Male , Metabolome , Young Adult
12.
Diagn Pathol ; 9: 97, 2014 May 26.
Article in English | MEDLINE | ID: mdl-24886298

ABSTRACT

BACKGROUND: Programmed death-1 (PD-1, Pdcd1)-deficient mice develop different types of autoimmune diseases depending on the mouse strain but its role in uterus development has not been reported. METHODS: In this study, the expression of PD-1 and its ligands, PD-L1 and PD-L2, in uterine tissues from aged WT mice in a 129svEv-Brd background was analyzed by immunohistochemistry and the uterine morphology between WT and PD-1-/- mice was compared by hematoxylin and eosin staining. RESULTS: The aged PD-1-/- female mice in a 129svEv-Brd rather than Balb/c background develop endometrial hyperplasia. H&E staining showed an increase in the number of glands, neovascularization and an extremely large luminal cavity in aged PD-1-/- uteri. Immunohistochemical assay showed that the expression of PD-1 was observed in glandular/luminal epithelium and cells infiltrating the stroma. Fluorescent double staining demonstrated that PD-1 expresses on CD68+ macrophages, CD3+ T cells, CD16+ monocytes, CD56+ NK cells and CK-18+ epithelial cells, respectively. Additionally, PD-1 co-expresses with vascular endothelial growth factor (VEGF), and PD-1 deficiency resulted in an accumulation of glandular/luminal epithelium derived VEGF, which accelerates the expression of the proliferation-associated protein, proliferating cell nuclear antigen (PCNA), and thus potentially lead to epithelial proliferation in aged PD-1-/- uteri. CONCLUSIONS: These findings showed that PD-1 deficiency augments luminal epithelial cell proliferation probably through induced VEGF secretion, suggesting PD-1 plays an important role in controlling the growth and differentiation of the uterine epithelium. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/5809067461223905.


Subject(s)
Cell Proliferation , Endometrial Hyperplasia/metabolism , Endometrium/metabolism , Epithelial Cells/metabolism , Programmed Cell Death 1 Receptor/deficiency , Animals , B7-H1 Antigen/metabolism , Cell Differentiation , Disease Models, Animal , Endometrial Hyperplasia/genetics , Endometrial Hyperplasia/pathology , Endometrium/blood supply , Endometrium/pathology , Epithelial Cells/pathology , Female , Mice, 129 Strain , Mice, Inbred BALB C , Mice, Knockout , Neovascularization, Pathologic , Programmed Cell Death 1 Ligand 2 Protein/metabolism , Programmed Cell Death 1 Receptor/genetics , Signal Transduction , Vascular Endothelial Growth Factor A/metabolism
13.
Cell Biochem Biophys ; 70(2): 1427-32, 2014 Nov.
Article in English | MEDLINE | ID: mdl-24965166

ABSTRACT

Acute mountain sickness (AMS) is the most common high altitude illnesses experienced during rapid ascent to a higher altitude without prior acclimation. It is mainly characterized by a headache which may be accompanied with nausea, vomiting, anorexia, dizziness, lethargy, fatigue, and sleep disturbance. If not diagnosed and treated in a timely manner, AMS can develop into deadly high altitude pulmonary edema or high altitude cerebral edema. In the previous studies of individual variation in susceptibility to AMS, arterial oxygen saturation (SO2) was identified as being associated with AMS. However, other studies have reported no association between AMS and arterial oxygen saturation. In this study, the association between SO2 and AMS was assessed through a meta-analysis of published data. The literature databases PubMed, Web of Science, LWW, Science Direct, and Embase were queried for papers published before 15 April 2014. A fixed-effects model and a random-effects model were applied (Revman 5.0) on the basis of heterogeneity, and the study quality was assessed in duplicate. Twelve studies with 614 AMS patients and 1,025 control subjects were analyzed. There was a significant association with differences in SO2 and the risk of developing AMS. SO2 values are associated with AMS incidence.


Subject(s)
Altitude Sickness/metabolism , Arteries/metabolism , Oxygen/metabolism , Acute Disease , Humans
14.
Gut ; 62(8): 1204-13, 2013 Aug.
Article in English | MEDLINE | ID: mdl-22637698

ABSTRACT

OBJECTIVES: Fulminant viral hepatitis (FH) remains a serious clinical problem for which the underlying pathogenesis remains unclear. The B and T lymphocyte attenuator (BTLA) is an immunoglobulin-domain-containing protein that has the capacity to maintain peripheral tolerance and limit immunopathological damage during immune responses. However, its precise role in FH has yet to be investigated. DESIGN: BTLA-deficient (BTLA-/-) mice and their wild-type littermates were infected with murine hepatitis virus strain-3 (MHV-3), and the levels of tissue damage, cell apoptosis, serum liver enzymes, fibrinogen-like protein 2 (FGL2) and cytokine production were measured and compared. Survival rate was studied after MHV-3 infection with or without adoptive transferring macrophages. RESULTS: FGL2 production, liver and spleen damage, and mortality were significantly reduced in BTLA-/- mice infected with MHV-3. This effect is due to rapid, TRAIL (TNF-related apoptosis-inducing ligand)-dependent apoptosis of MHV-3-infected macrophages in BTLA-/- mice. The early loss of macrophages resulted in reduced pathogenic tumour necrosis factor α (TNFα) and FGL2 levels and lower viral titres. The importance of TNFα in MHV-3-induced pathology was demonstrated by increased mortality in TNFα-treated MHV-3-infected BTLA-/- mice, whereas TNFα-/- mice were resistant to the infection. Moreover, adoptively transferring macrophages to BTLA-/- mice caused sensitisation, whereas blocking BTLA protected wild-type mice from virus-induced FH mortality. CONCLUSIONS: BTLA promotes the pathogenesis of virus-induced FH by enhancing macrophage viability and function. Targeting BTLA may be a novel strategy for the treatment of FH.


Subject(s)
Coronavirus Infections/immunology , Hepatitis, Viral, Animal/immunology , Macrophages/immunology , Murine hepatitis virus , Receptors, Immunologic/immunology , Adoptive Transfer , Animals , Apoptosis/immunology , Coronavirus Infections/pathology , Coronavirus Infections/prevention & control , Hepatitis, Viral, Animal/pathology , Hepatitis, Viral, Animal/prevention & control , Macrophages/pathology , Macrophages/transplantation , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Knockout , Receptors, Immunologic/biosynthesis , Receptors, Immunologic/deficiency , TNF-Related Apoptosis-Inducing Ligand/immunology , Tumor Necrosis Factor-alpha/biosynthesis
15.
Inflammation ; 36(1): 110-20, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22895698

ABSTRACT

Hepatitis B virus (HBV) infection is a major public health problem, and HBV-related acute-on-chronic liver failure (HBV-ACLF) has an extremely poor prognosis due to a lack of understanding of pathogenesis as well as a lack of effective treatments. Signals from the inhibitory receptor programmed death-1 (PD-1) have been demonstrated to be involved in regulating the pathogenesis of infectious diseases. However, the expression of PD-1 and its ligands in HBV-ACLF patients has yet to be evaluated. In this study, the expression of PD-1 and its ligands, PD-L1 and PD-L2, in liver biopsies from HBV-ACLF as well as chronic hepatitis B (CHB) patients were analyzed by immunohistochemistry. The results showed that all three molecules were observed in the HBV-ACLF samples and their levels were significantly higher than they were in CHB. Immunofluorescence double-staining showed that PD-1 was found on CD3(+), CD8(+) T cells, CD56(+) NK cells, CD68(+) macrophages, CK-18(+) epithelial cells, and CD16(+) monocytes. The PD-L1 expression was observed on all cell types detected and the PD-L2 was chiefly on CK-18(+) epithelial cells and CD31(+) endothelial cells. Interestingly, high levels of virus-induced procoagulant molecule fibrinogen-like protein 2 (FGL2) were observed in liver sections from HBV-ACLF, and PD-L1 and PD-L2 expression was also observed on FGL2(+) cells in these patients. Our combined results suggest that the expression of PD-L1 and PD-L2 may be biomarkers to identify and diagnose ACLF, and a clear understanding of their functional roles should further elucidate the pathogenesis of this disease.


Subject(s)
B7-H1 Antigen/biosynthesis , Hepatitis B, Chronic/metabolism , Programmed Cell Death 1 Ligand 2 Protein/biosynthesis , Programmed Cell Death 1 Receptor/biosynthesis , Apoptosis , Biomarkers , CD8-Positive T-Lymphocytes/metabolism , End Stage Liver Disease/metabolism , End Stage Liver Disease/virology , Epithelial Cells/metabolism , Fibrinogen/biosynthesis , Hepatitis B virus , Hepatitis B, Chronic/immunology , Hepatitis B, Chronic/virology , Humans , Killer Cells, Natural/metabolism , Ligands , Liver/metabolism , Liver Failure, Acute/metabolism , Liver Failure, Acute/virology , Macrophages/metabolism , Monocytes/metabolism , Viral Load
16.
J Mol Histol ; 44(2): 213-20, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23264111

ABSTRACT

Signals from the T cell immunoglobulin and mucin-domain (TIM)-containing molecules have been demonstrated to be involved in regulating the progress of carcinoma. However, the expression and anatomical distribution of TIMs in Langerhans cell sarcoma (LCS), which is a rare malignancy derived from dendritic cells of the epidermis, has yet to be determined. In this study, the expression of TIM-1, TIM-3 and TIM-4 in LCS samples were detected by immunohistochemistry. Our results showed that these three molecules were found in LCS sections. At the cellular level, these molecules were found on the cell membrane and in the cytoplasm. Immunofluorescence double-staining demonstrated that these TIMs were co-expressed with Langerin, a potential biomarker for detecting LCS. In addition, TIM-1 was also expressed on CD68(+) macrophages and CK-18(+) epithelial cells, while TIM-3 and TIM-4 were expressed on all cell types investigated, including CD3(+)T cells, CD68(+) macrophages, CD11c(+) dendritic cells, CD16(+) NK Cells, CD31(+) endothelial cells and CK-18(+) epithelial cells. Interestingly, TIMs were also co-expressed with some members of the B7 superfamily, including B7-H1, B7-H3 and B7-H4 on sarcoma cells. Our results clearly showed the characteristic expression and anatomical distribution of TIMs in LCS, and a clear understanding of their functional roles may further elucidate the pathogenesis of this carcinoma and potentially contribute to the development of novel immunotherapeutic strategies.


Subject(s)
Cell Cycle Proteins/metabolism , Intracellular Signaling Peptides and Proteins/metabolism , Langerhans Cell Sarcoma/metabolism , B7 Antigens/metabolism , Cell Cycle Proteins/genetics , Gene Expression , Humans , Immunohistochemistry , Intracellular Signaling Peptides and Proteins/genetics , Intracellular Space/metabolism , Phenotype , Protein Transport
17.
Diagn Pathol ; 7: 142, 2012 Oct 15.
Article in English | MEDLINE | ID: mdl-23067542

ABSTRACT

OBJECTIVE: It has been demonstrated that signals from the inhibitory receptor B and T lymphocyte attenuator (BTLA) are involved in regulating the pathogenesis of infectious diseases. However, the expression and anatomical distribution of BTLA and its ligand, the herpes virus entry mediator (HVEM), have not yet been determined in cases of HBV-related acute-on-chronic liver failure (HBV-ACLF) patients. METHODS: In this study, the expression of BTLA and HVEM in liver tissues from HBV-ACLF, chronic hepatitis B (CHB) patients and healthy individuals was analyzed by immunohistochemistry. RESULTS: The results of this analysis demonstrated that both molecules were observed in the HBV-ACLF samples and that their expression was chiefly in the infiltrating inflammatory cells and the damaged bile ducts. However, they were absent in liver sections from CHB patients and healthy controls. Immunofluorescence double-staining indicated that BTLA was found on CK-18+ epithelial cells, CD31+ endothelial cells, CD68+ macrophages, CD56+ NK cells, CD16+ monocytes, CD3+ , CD8+ T cells, and Foxp3+ regulatory T cells (Treg). By contrast, HVEM expression was restricted to CK18+ epithelial cells and CD68+ macrophages. Moreover, the expression of several members of the B7 superfamily, including PD-L1, PD-L2, B7-H3 and B7-H4, was also detected in these liver tissues, and these proteins were co-expressed with HVEM. Interestingly, the expression of fibrinogen-like protein 2 (FGL2), a virus-induced procoagulant molecule, was also found in liver sections from HBV-ACLF, this molecule also co-expresses with BTLA and HVEM. CONCLUSIONS: These results suggest that BTLA-HVEM signaling is likely to affect the pathogenesis of HBV-ACLF, a clear understanding of the functional roles of these proteins should further elucidate the disease process. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/8080806838149123.


Subject(s)
End Stage Liver Disease/metabolism , Hepatitis B, Chronic/complications , Liver Failure, Acute/metabolism , Liver/chemistry , Receptors, Immunologic/analysis , Receptors, Tumor Necrosis Factor, Member 14/analysis , Bile Ducts, Intrahepatic/chemistry , Biomarkers/analysis , Biopsy , Case-Control Studies , End Stage Liver Disease/pathology , End Stage Liver Disease/virology , Endothelial Cells/chemistry , Epithelial Cells/chemistry , Fluorescent Antibody Technique , Hepatitis B, Chronic/pathology , Hepatitis B, Chronic/virology , Humans , Immunohistochemistry , Ligands , Liver/pathology , Liver/virology , Liver Failure, Acute/pathology , Liver Failure, Acute/virology , Macrophages/chemistry , Phenotype , T-Lymphocytes/chemistry
18.
Pathol Int ; 62(10): 665-74, 2012 Oct.
Article in English | MEDLINE | ID: mdl-23005593

ABSTRACT

Hepatitis B virus (HBV) is a major public health problem, and HBV-related acute-on-chronic liver failure (HBV-ACLF) has an extremely poor prognosis due to a lack of effective treatments. B7-H3 and B7-H4 are two novel members of the B7 superfamily that are actively involved in regulating the pathogenesis of infectious diseases. However, the intrahepatic expression of both members in HBV-ACLF patients has yet to be described. In this study, we analyzed the expression of B7-H3 and B7-H4 in HBV-ACLF biopsies by immunohistochemistry. Our results showed that both members were observed in all HBV-ACLF samples, and their expression was chiefly observed on infiltrating inflammatory cells and the damaged bile ducts. Immunofluorescence double staining showed that B7-H4 was expressed chiefly on CD3(+) T cells, CD68(+) macrophages, CK-18(+) bile ducts, and CD31(+) endothelial cells, while B7-H3 was found on all cell types detected. The expression of the programmed death (PD)-1 ligands, PD-L1 and PD-L2, was also detected in these liver tissues and they were found to be co-expressed with B7-H3 and B7-H4. These results suggest that the B7-family signaling is most likely to affect the pathogenesis of this disease, and a clear understanding of their functional roles may further elucidate the disease process.


Subject(s)
B7 Antigens/metabolism , End Stage Liver Disease/metabolism , Hepatitis B virus/pathogenicity , Hepatitis B, Chronic/metabolism , Liver Failure, Acute/metabolism , V-Set Domain-Containing T-Cell Activation Inhibitor 1/metabolism , Adult , Aged , B7-H1 Antigen/metabolism , Bile Ducts , Biomarkers/metabolism , Biopsy , Disease Progression , End Stage Liver Disease/immunology , End Stage Liver Disease/virology , Hepatitis B, Chronic/immunology , Hepatitis B, Chronic/virology , Humans , Immunohistochemistry , Liver/metabolism , Liver Failure, Acute/immunology , Liver Failure, Acute/virology , Macrophages/immunology , Male , Middle Aged , Phenotype , Prognosis , Programmed Cell Death 1 Ligand 2 Protein/metabolism , T-Lymphocytes/immunology
19.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi ; 28(6): 643-6, 2012 Jun.
Article in Chinese | MEDLINE | ID: mdl-22691359

ABSTRACT

AIM: To detect the expression of B and T lymphocyte attenuator (BTLA) antigen in synovial tissues from rheumatoid arthritis (RA) patients. METHODS: The expression and distribution of BTLA antigen was analyzed by immunohistochemistry. Moreover, fluorescence double-staining was used to further identify the cell types expressing BTLA. RESULTS: Immunohistochemical analysis revealed that a great deal of BTLA positive cells were found in RA synovium, and fluorescence double-staining further demonstrated that BTLA positive cells were CD3(+); T cells, CD68(+); macrophages, and occasionally CD31(+); endothelial cells. In contrast to other members of B7 superfamily, the expression of BTLA was also found on B7-H1(+);, B7-H4(+); and HVEM(+); cells, while it was absence on B7-DC(+); cells as well as B7-H3(+); cells. CONCLUSION: The expression of BTLA has been observed on the surface of several kinds of cells within synovial tissues of RA patients, which indicates this signal might be involved in the regulation of local T cell activation and the pathogenesis of RA.


Subject(s)
Arthritis, Rheumatoid/metabolism , Receptors, Immunologic/metabolism , Synovial Membrane/metabolism , Arthritis, Rheumatoid/immunology , B7 Antigens/immunology , B7 Antigens/metabolism , Humans , Immunohistochemistry , Lymphocyte Activation/immunology , T-Lymphocytes/immunology
20.
Acta Histochem ; 114(7): 733-43, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22305414

ABSTRACT

Langerhans cell sarcoma (LCS) is a rare malignancy derived from dendritic cells of the epidermis that is characterized by cytological atypia, frequent mitoses, and aggressive clinical behavior. Cancer-associated B7 molecules including B7-H1, B7-DC, B7-H3 and B7-H4 are thought to be involved in the immunoescape of cancer cells and to function as prognostic markers. However, the expression and distribution of these molecules in LCS have not been described. Here we report that all of these molecules were observed in LCS sample sections by immunohistochemistry analysis. At the cellular level, they were found on the cell membrane and in the cytoplasm. Fluorescence dual staining indicated that B7-H1, B7-H3 and B7-H4 were principally associated with Langerin(+) tumor cells. More interestingly, B7-H1, B7-H3 and B7-H4 were co-expressed on the same tumor cells. Z39Ig, the novel B7-related protein, was also found in the LCS sample sections. Fluorescence dual staining showed that Z39Ig was restricted on CD68(+) macrophages. Our results suggest that B7-H1, B7-H3 and B7-H4 may be potential biomarkers to identify LCS, and a clear understanding of their functional roles may further elucidate the pathogenesis of this carcinoma and potentially contribute to the development of novel immunotherapeutic strategies.


Subject(s)
B7 Antigens/metabolism , Biomarkers, Tumor/metabolism , Langerhans Cell Sarcoma/metabolism , Skin Neoplasms/metabolism , Humans , Langerhans Cell Sarcoma/pathology , Macrophages/metabolism , Receptors, Complement/metabolism , Skin Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL